Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-14-002744
Filing Date
2014-08-07
Accepted
2014-08-07 16:44:30
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT txmd-10q_063014.htm 10-Q 546360
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 11702
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 11795
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 5135
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 5095
  Complete submission text file 0001387131-14-002744.txt   3746946

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT txmd-20140630.xml EX-101.INS 384072
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20140630.xsd EX-101.SCH 37666
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT txmd-20140630_cal.xml EX-101.CAL 64841
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT txmd-20140630_def.xml EX-101.DEF 130408
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20140630_lab.xml EX-101.LAB 289569
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20140630_pre.xml EX-101.PRE 227998
Mailing Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487
Business Address 6800 BROKEN SOUND PARKWAY NW THIRD FLOOR BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 141024493
SIC: 2834 Pharmaceutical Preparations